Skip to main content
OpenTrials

Clinical trial condition

Carcinoma in Situ

Explore clinical trials studying Carcinoma in Situ. Study availability and eligibility vary by location and protocol.

309 public trials 56 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma in Situ trial results

Active, not recruiting

Breast Cancer WEight Loss Study (BWEL Study)

NCT02750826

Conditions
Adenocarcinoma, Breast Carcinoma In Situ, Breast Diseases, +18 more
Locations
  • Southern Cancer Center PC-Daphne Daphne, Alabama, United States
  • Southern Cancer Center PC-Mobile Mobile, Alabama, United States
  • Southern Cancer Center PC-Providence Mobile, Alabama, United States
  • Southern Cancer Center PC-Springhill Mobile, Alabama, United States
View all 1498 locations
View Trial Details
Active, not recruiting

Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

NCT02954874

Conditions
Breast Carcinoma In Situ, Breast Carcinoma in Situ, Breast Diseases, +15 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Southern Cancer Center PC-Daphne Daphne, Alabama, United States
  • Southern Cancer Center PC-Mobile Mobile, Alabama, United States
  • Southern Cancer Center PC-Providence Mobile, Alabama, United States
View all 919 locations
View Trial Details
Active, not recruiting

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

NCT01272037

Conditions
Adenocarcinoma, Breast Carcinoma In Situ, Breast Ductal Carcinoma in Situ, +11 more
Locations
  • Northeast Alabama Regional Medical Center Anniston, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Providence Hospital Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
View all 1568 locations
View Trial Details
Active, not recruiting

Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer

NCT01266642

Conditions
Adenocarcinoma, Breast Carcinoma In Situ, Breast Diseases, +19 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • UF Cancer Center at Orlando Health Orlando, Florida, United States
  • MD Anderson in The Woodlands Conroe, Texas, United States
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details
Active, not recruiting

Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS

NCT02926911

Conditions
Adenocarcinoma, Breast Carcinoma In Situ, Carcinoma, +9 more
Locations
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 141 locations
View Trial Details

Related conditions